香港股市 已收市

Danaher Corporation (DHR)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
246.58+0.78 (+0.32%)
收市:04:00PM EDT
246.02 -0.56 (-0.23%)
收市後: 07:43PM EDT

Danaher Corporation

2200 Pennsylvania Avenue, North West
Suite 800 West
Washington, DC 20037-1701
United States
202 828 0850
https://www.danaher.com

版塊Healthcare
行業Diagnostics & Research
全職員工61,000

高階主管

名稱頭銜支付行使價出生年份
Mr. Steven M. RalesCo-Founder & Chairman1951
Mr. Rainer M. BlairPresident, CEO & Director5.33M1964
Mr. Mitchell P. RalesCo-Founder & Director1957
Mr. Matthew R. McGrewCFO & Executive VP2.56M1972
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior VP & Chief Science Officer2.09M1962
Ms. Georgeann F. CoucharaSenior Vice President of Human Resources1.66M1977
Mr. Joakim WeidemanisExecutive Vice President2.76M6.5M1969
Mr. Christopher M. BoudaVP & Chief Accounting Officer
Mr. John BedfordVice President of Investor Relations
Mr. Brian W. EllisSenior VP, General Counsel & Chief Compliance Officer1.93M1967
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

公司管治

截至 2024年4月1日 止,Danaher Corporation 的 ISS 管治質素評分為 7。 Pillar 分數正在審核中:9;董事會:10;股東權利:2;現金賠償:2。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。